Skip to main content
NASDAQ:CRZNU

Corazon Capital V838 Monoceros Competitors

$9.98
-0.02 (-0.20 %)
(As of 05/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.98
$9.99
50-Day Range
$9.80
$10.04
52-Week Range
$9.75
$10.88
Volume1,000 shs
Average Volume49,802 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Corazon Capital V838 Monoceros (NASDAQ:CRZNU) Vs. AFAQU, ANEB, ANZUU, ATSPU, ARRWU, and AUUD

Should you be buying CRZNU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to Corazon Capital V838 Monoceros, including AF Acquisition (AFAQU), Anebulo Pharmaceuticals (ANEB), Anzu Special Acquisition Corp I (ANZUU), Archimedes Tech SPAC Partners (ATSPU), Arrowroot Acquisition (ARRWU), and Auddia (AUUD).

AF Acquisition (NASDAQ:AFAQU) and Corazon Capital V838 Monoceros (NASDAQ:CRZNU) are both -- companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and price targets for AF Acquisition and Corazon Capital V838 Monoceros, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AF Acquisition0000N/A
Corazon Capital V838 Monoceros0000N/A

Profitability

This table compares AF Acquisition and Corazon Capital V838 Monoceros' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AF AcquisitionN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/A

Earnings and Valuation

This table compares AF Acquisition and Corazon Capital V838 Monoceros' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AF AcquisitionN/AN/AN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/AN/AN/A

Anebulo Pharmaceuticals (NASDAQ:ANEB) and Corazon Capital V838 Monoceros (NASDAQ:CRZNU) are both -- companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Anebulo Pharmaceuticals and Corazon Capital V838 Monoceros' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anebulo PharmaceuticalsN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/A

Earnings and Valuation

This table compares Anebulo Pharmaceuticals and Corazon Capital V838 Monoceros' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anebulo PharmaceuticalsN/AN/AN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Anebulo Pharmaceuticals and Corazon Capital V838 Monoceros, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anebulo Pharmaceuticals0000N/A
Corazon Capital V838 Monoceros0000N/A

Anzu Special Acquisition Corp I (NASDAQ:ANZUU) and Corazon Capital V838 Monoceros (NASDAQ:CRZNU) are both -- companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Anzu Special Acquisition Corp I and Corazon Capital V838 Monoceros' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anzu Special Acquisition Corp IN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/A

Valuation and Earnings

This table compares Anzu Special Acquisition Corp I and Corazon Capital V838 Monoceros' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Anzu Special Acquisition Corp I and Corazon Capital V838 Monoceros, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anzu Special Acquisition Corp I0000N/A
Corazon Capital V838 Monoceros0000N/A

Archimedes Tech SPAC Partners (NASDAQ:ATSPU) and Corazon Capital V838 Monoceros (NASDAQ:CRZNU) are both -- companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Archimedes Tech SPAC Partners and Corazon Capital V838 Monoceros' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Archimedes Tech SPAC PartnersN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/A

Valuation and Earnings

This table compares Archimedes Tech SPAC Partners and Corazon Capital V838 Monoceros' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Archimedes Tech SPAC PartnersN/AN/AN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Archimedes Tech SPAC Partners and Corazon Capital V838 Monoceros, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Archimedes Tech SPAC Partners0000N/A
Corazon Capital V838 Monoceros0000N/A

Arrowroot Acquisition (NASDAQ:ARRWU) and Corazon Capital V838 Monoceros (NASDAQ:CRZNU) are both -- companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Arrowroot Acquisition and Corazon Capital V838 Monoceros' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Arrowroot AcquisitionN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/A

Valuation and Earnings

This table compares Arrowroot Acquisition and Corazon Capital V838 Monoceros' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arrowroot AcquisitionN/AN/AN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Arrowroot Acquisition and Corazon Capital V838 Monoceros, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Arrowroot Acquisition0000N/A
Corazon Capital V838 Monoceros0000N/A

Auddia (NASDAQ:AUUD) and Corazon Capital V838 Monoceros (NASDAQ:CRZNU) are both -- companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Auddia and Corazon Capital V838 Monoceros' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AuddiaN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Auddia and Corazon Capital V838 Monoceros, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Auddia0000N/A
Corazon Capital V838 Monoceros0000N/A

Valuation and Earnings

This table compares Auddia and Corazon Capital V838 Monoceros' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AuddiaN/AN/AN/AN/AN/A
Corazon Capital V838 MonocerosN/AN/AN/AN/AN/A


Corazon Capital V838 Monoceros Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
AFAQU
AF Acquisition
0.0$9.95-0.5%$0.00N/A0.00
ANEB
Anebulo Pharmaceuticals
0.0$7.00-0.0%$0.00N/A0.00
ANZUU
Anzu Special Acquisition Corp I
0.0$9.98-0.2%$0.00N/A0.00
ATSPU
Archimedes Tech SPAC Partners
0.0$9.98-0.2%$0.00N/A0.00
ARRWU
Arrowroot Acquisition
0.0$9.99-0.1%$0.00N/A0.00
AUUD
Auddia
0.0$2.42-0.8%$0.00N/A0.00
BRIVU
B. Riley Principal 250 Merger Corp. Units
0.0$9.99-0.1%$0.00N/A0.00
BSA
BrightSphere Investment Group
0.0$25.20-0.3%$0.00N/A0.00
CPZ
Calamos Long/Short Equity & Dynamic Income Term Trust
0.0$20.36-0.3%$0.00N/A0.00
CMLTU
CM Life Sciences III
0.0$10.52-1.6%$0.00N/A0.00Quiet Period Expiration
Gap Up
DKDCU
Data Knights Acquisition Corp. Unit
0.0$10.09-0.0%$0.00N/A0.00
DCRCU
Decarbonization Plus Acquisition Corp III
0.0$9.96-0.4%$0.00N/A0.00
DLY
DoubleLine Yield Opportunities Fund
0.0$19.66-0.1%$0.00N/A0.00
EBACU
European Biotech Acquisition
0.0$10.00-0.5%$0.00N/A0.00
EVOJ
Evo Acquisition
0.3$9.77-0.0%$0.00N/A0.00
FRSGU
First Reserve Sustainable Growth
0.0$9.99-0.0%$0.00N/A0.00
FMIVU
Forum Merger IV
0.0$9.96-0.0%$0.00N/A0.00
FRONU
Frontier Acquisition
0.0$10.08-0.3%$0.00N/A0.00
HERAU
FTAC Hera Acquisition
0.0$9.99-0.1%$0.00N/A0.00
GLHAU
Glass Houses Acquisition
0.0$10.00-0.3%$0.00N/A0.00
GLSPU
Global SPAC Partners
0.0$10.00-0.2%$0.00N/A0.00Quiet Period Expiration
GMLPP
Golar LNG Partners LP 8.75% CUM PFD A
0.8$23.25-0.7%$0.00N/A0.00
GAMCU
Golden Arrow Merger
0.0$9.95-0.2%$0.00N/A0.00
GBRGU
Goldenbridge Acquisition
0.0$10.45-0.0%$0.00N/A0.00
GSEVU
Gores Holdings VII
0.0$10.00-0.1%$0.00N/A0.00
HGLB
Highland Global Allocation Fund
0.3$8.67-1.3%$0.00N/A0.00
IPVIU
InterPrivate IV InfraTech Partners
0.0$10.00-0.3%$0.00N/A0.00
ISLEU
Isleworth Healthcare Acquisition
0.0$9.90-0.0%$0.00N/A0.00
KSICU
Kadem Sustainable Impact
0.0$9.98-0.1%$0.00N/A0.00
LCAAU
L Catterton Asia Acquisition
0.0$10.03-0.3%$0.00N/A0.00
LEGAU
Lead Edge Growth Opportunities
0.0$9.97-0.1%$0.00N/A0.00
LVRAU
Levere
0.0$10.01-0.0%$0.00N/A0.00
LEV
Lion Electric
1.7$15.03-5.0%$0.00N/A0.00Analyst Revision
MHNC
Maiden Holdings North America
0.8$23.67-1.1%$0.00N/A0.00
MAQCU
Maquia Capital Acquisition Co. Unit
0.0$10.00-0.2%$0.00N/A0.00
NMCO
Nuveen Municipal Credit Opportunities Fund
0.0$14.88-0.4%$0.00N/A0.00
PIMCO Energy and Tactical Credit Opportunities Fund logo
NRGX
PIMCO Energy and Tactical Credit Opportunities Fund
0.8$11.10-0.1%$0.00N/A0.00Insider Buying
PYT
PPLUS Trust Series GSC-2 GSC 2 CT FL RT
0.4$24.00-0.0%$0.00N/A0.00Dividend Cut
News Coverage
FRWAU
PWP Forward Acquisition Corp. I
0.0$10.00-0.0%$0.00N/A0.00
RTPYU
Reinvent Technology Partners Y
0.0$10.07-0.1%$0.00N/A0.00
RXRAU
RXR Acquisition
0.0$9.99-0.0%$0.00N/A0.00
SPKBU
Silver Spike Acquisition Corp II
0.0$10.00-0.1%$0.00N/A0.00
SBEAU
SilverBox Engaged Merger Corp I
0.0$9.98-0.2%$0.00N/A0.00
SRNGU
Soaring Eagle Acquisition
0.0$10.25-0.1%$0.00N/A0.00
TALS
Talaris Therapeutics
0.3$14.37-9.2%$0.00N/A0.00Insider Buying
TBSAU
TB SA Acquisition
0.0$9.95-0.0%$0.00N/A0.00
TCVA
TCV Acquisition
0.0$10.02-1.3%$0.00N/A0.00
TEAF
Tortoise Essential Assets Income Term Fund
0.9$14.23-0.1%$0.00N/A0.00Dividend Announcement
News Coverage
TravelCenters of America LLC 8% SR NT 2030 logo
TANNZ
TravelCenters of America LLC 8% SR NT 2030
0.7$25.82-0.5%$0.00N/A0.00
TravelCenters of America LLC SR NT logo
TANNL
TravelCenters of America LLC SR NT
0.5$25.87-1.1%$0.00N/A0.00
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.